The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial
Open accessAbstract
Importance: Antipsychotics are widely used for distressing symptoms of delirium, but efficacy has not been established in placebo-controlled trials in palliative care. Objective: To determine efficacy of risperidone or haloperidol relative to placebo in relieving target symptoms of delirium associated with distress among patients receiving palliative care. Design, Setting, and Participants: A double-blind, parallel-arm, dose-titrated randomized clinical trial was conducted at 11 Australian inpatient hospice or hospital palliative care services between August 13, 2008, and April 2, 2014, among participants with life-limiting illness, delirium, and a delirium symptoms score (sum of Nursing Delirium Screening Scale behavioral, communication, and perceptual items) of 1 or more. Interventions: Age-adjusted titrated doses of oral risperidone, haloperidol, or placebo solution were administered every 12 hours for 72 hours, based on symptoms of delirium. Patients also received supportive care, individualized treatment of delirium precipitants, and subcutaneous midazolam hydrochloride as required for severe distress or safety. Main Outcome and Measures: Improvement in mean group difference of delirium symptom score (severity range, 0-6) between baseline and day 3. Five a priori secondary outcomes: delirium severity, midazolam use, extrapyramidal effects, sedation, and survival. Results: Two hundred forty-seven participants (mean [SD] age, 74.9 [9.8] years; 85 women [34.4%]; 218 with cancer [88.3%]) were included in intention-to-treat analysis (82 receiving risperidone, 81 receiving haloperidol, and 84 receiving placebo). In the primary intention-to-treat analysis, participants in the risperidone arm had delirium symptom scores that were significantly higher than those among participants in the placebo arm (on average 0.48 Units higher; 95% CI, 0.09-0.86; P = .02) at study end. Similarly, for those in the haloperidol arm, delirium symptom scores were on average 0.24 Units higher (95% CI, 0.06-0.42; P = .009) than in the placebo arm. Compared with placebo, patients in both active arms had more extrapyramidal effects (risperidone, 0.73; 95% CI, 0.09-1.37; P = .03; and haloperidol, 0.79; 95% CI, 0.17-1.41; P = .01). Participants in the placebo group had better overall survival than those receiving haloperidol (hazard ratio, 1.73; 95% CI, 1.20-2.50; P = .003), but this was not significant for placebo vs risperidone (hazard ratio, 1.29; 95% CI, 0.91-1.84; P = .14). Conclusions and Relevance: In patients receiving palliative care, individualized management of delirium precipitants and supportive strategies result in lower scores and shorter duration of target distressing delirium symptoms than when risperidone or haloperidol are added. Trial Registration: anzctr.org.au Identifier: ACTRN12607000562471.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Effectiveness of Multicomponent Nonpharmacological Delirium Interventions: A Meta-analysis
Hshieh, T. T., Yue, J., Oh, E., Puelle, M., Dowal, S., Travison, T., & Inouye, S. K. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7779 · Cited by 801
Occurrence, Causes, and Outcome of Delirium in Patients With Advanced Cancer: A Prospective Study
Lawlor, P. G., Gagnon, B., Mancini, I. L., Pereira, J. L., Hanson, J., Suarez-Almazor, M. E., & Bruera, E. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.786 · Cited by 800
Self-citationNeuropathogenesis of Delirium: Review of Current Etiologic Theories and Common Pathways
Maldonado, J. R. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.09.005 · Cited by 745
Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3018 · Cited by 617
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.231 · Cited by 617
Neufeld, K. J., Yue, J., Robinson, T. N., Inouye, S. K., & Needham, D. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14076 · Cited by 505 · cited 1×
“CIRS score, median (IQR) 24 (21-28) 23 (20-26) 25 (21-29)”
Girard, T. D., Pandharipande, P. P., Carson, S. S., Schmidt, G. A., Wright, P. E., Canonico, A. E., Pun, B. T., Thompson, J. L., Shintani, A. K., Meltzer, H. Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c58715 · Cited by 451
Page, V. J., Ely, E. W., Gates, S., Zhao, X. B., Alce, T., Shintani, A., Jackson, J., Perkins, G. D., & McAuley, D. F. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70166-8 · Cited by 410
Dorman, T. (2011) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(10)79437-5 · Cited by 385
A Nurse‐Led Interdisciplinary Intervention Program for Delirium in Elderly Hip‐Fracture Patients
Milisen, K., Foreman, M. D., Abraham, I. L., De Geest, S., Godderis, J., Vandermeulen, E., Fischler, B., Delooz, H. H., Spiessens, B., & Broos, P. L. O. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49109.x · Cited by 369
Hosie, A., Davidson, P. M., Agar, M., Sanderson, C. R., & Phillips, J. (2013) · Palliative Medicine · doi:10.1177/0269216312457214 · Cited by 331
Self-citationA Double-Blind Trial of Risperidone and Haloperidol for the Treatment of Delirium
Han, C.-S., & Kim, Y.-K. (2004) · Psychosomatics · doi:10.1016/s0033-3182(04)70170-x · Cited by 268
Evidence-Based Treatment of Delirium in Patients With Cancer
Breitbart, W., & Alici, Y. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8784 · Cited by 187
The delirium experience: A review
O'Malley, G., Leonard, M., Meagher, D., & O'Keeffe, S. T. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.05.017 · Cited by 180
Lacasse, H., Perreault, M. M., & Williamson, D. R. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h241 · Cited by 159
A randomized controlled trial of quetiapine versus placebo in the treatment of delirium
Tahir, T. A., Eeles, E., Karapareddy, V., Muthuvelu, P., Chapple, S., Phillips, B., Adyemo, T., Farewell, D., & Bisson, J. I. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.05.006 · Cited by 158
Pitkälä, K. H., Laurila, J., Strandberg, T. E., & Tilvis, R. S. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.2.176 · Cited by 153
de la Cruz, M., Fan, J., Yennu, S., Tanco, K., Shin, S., Wu, J., Liu, D., & Bruera, E. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2610-3 · Cited by 152
Reversibility of delirium in terminally ill patients and predictors of mortality
Leonard, M. M., Raju, B., Conroy, M., Donnelly, S. M., Trzepacz, P. T., Saunders, J. A., & Meagher, D. J. (2008) · Palliative Medicine · doi:10.1177/0269216308094520 · Cited by 114
Consensus and variations in opinions on delirium care: a survey of European delirium specialists
Morandi, A., Davis, D. H. J., Taylor, J., Bellelli, G., Olofsson, B., Kreisel, S. H., Teodorczuk, A., Kamholz, B. A., Hasemann, W., Young, J. B., et al. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001415 · Cited by 100
Self-citationManeeton, N., Maneeton, B., Srisurapanon, & Chittawatanarat, K. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s45575 · Cited by 94
Risperidone versus olanzapine for the treatment of delirium
Kim, S., Yoo, J., Lee, S. Y., Kim, S., Bae, K., Yang, S., Kim, J., Shin, I., & Yoon, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1117 · Cited by 91
Physicians Vary in Approaches to the Clinical Management of Delirium
Carnes, M. L., Howell, T., Rosenberg, M. A., Francis, J., Hildebrand, C. J., & Knüppel, J. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51063.x · Cited by 85
Lawlor, P. G., Davis, D. H. J., Ansari, M. T., Hosie, A., Kanji, S., Momoli, F., Bush, S. H., Watanabe, S., Currow, D. C., Gagnon, B., et al. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.12.245 · Cited by 51
Self-citationOlanzapine and haloperidol for senile delirium: A randomized controlled observation
Hu, H., Deng, W., Yang, H., & Liu, Y. (2006) · Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu · Cited by 35
Family Caregivers’ Knowledge of Delirium and Preferred Modalities for Receipt of Information
Bull, M. J., Boaz, L., & Avery, J. S. (2014) · Journal of Applied Gerontology · doi:10.1177/0733464814535484 · Cited by 27
Differing management of people with advanced cancer and delirium by four sub-specialties
Agar, M. R., Currow, D. C., Plummer, J., Chye, R., & Draper, B. (2008) · Palliative Medicine · doi:10.1177/0269216308088691 · Cited by 21
Self-citation
Cited by
Wilson, J. E., Mart, M. F., Cunningham, C., Shehabi, Y., Girard, T. D., MacLullich, A. M. J., Slooter, A. J. C., & Ely, E. W. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00223-4 · Cited by 1,200
Delirium in Older Persons: Advances in Diagnosis and Treatment
Oh, E. S., Fong, T. G., Hshieh, T. T., & Inouye, S. K. (2017) · JAMA · doi:10.1001/jama.2017.12067 · Cited by 926
Postoperative delirium: perioperative assessment, risk reduction, and management
Jin, Z., Hu, J., & Ma, D. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.06.063 · Cited by 697
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Metadata
- Authors
- Agar, M. R., Lawlor, P. G., Quinn, S., Draper, B., Caplan, G. A., Rowett, D., Sanderson, C., Hardy, J., Le, B., Eckermann, S., McCaffrey, N., Devilee, L., Fazekas, B., Hill, M., & Currow, D. C.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2017-01-01
- Volume
- 177
- Issue
- 1
- Pages
- 34
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2560040996
- Cited by
- 344
- References
- 28
- FWCI
- 34.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.